Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App





Thermo Fisher Introduces New Solutions for Fast and Sensitive Nucleic Acid Detection

By LabMedica International staff writers
Posted on 20 Jul 2023

Thermo Fisher Scientific Inc. More...

(Waltham, MA; USA) is presenting its dynamic range of products at AACC 2023 that can help laboratories maximize productivity and innovation. In addition, Thermo Fisher is hosting industry-leading workshops where experts will be discussing the company’s latest innovations for preeclampsia testing with its new biomarkers PlGF and sFlt-1 that can help manage preeclampsia and neuroendocrine tumors.

During this session, Thermo Fisher is presenting two new product offers. The first is a new direct RT-qPCR system that can be used to amplify nucleic acid from inhibitor-enriched samples. The latest data demonstrates new reagents and workflow conditions that work best on saliva and serum samples. Second, the company will discuss the new Invitrogen Lyo-ready Bst DNA Polymerase for RT-LAMP isothermal amplification. This best-in-class enzyme demonstrates the highest speed, sensitivity, and resistance to inhibitor performance in LAMP reactions. Together, the Invitrogen Lyo-ready SuperScript IV Reverse Transcriptase and Invitrogen Lyo-ready RNaseOUT RNase Inhibitors offer the fastest solution for pathogen diagnostics using RT-LAMP.

At AACC 2023, Thermo Fisher is offering live demonstrations of its Indiko and Indiko Plus clinical and specialty chemistry analyzers that are easy-to-use, cost-effective, and designed for load-up and walk-away convenience. An intuitive user interface and many automated features help labs manage their daily workflow. These self-contained analyzers have small footprints and fit well in laboratories with space limitations. Thermo Fisher is also demonstrating the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System and Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System. Thermo Fisher is also offering live demonstrations of its new Diomni Enterprise software which combines instruments, assays, and consumables to streamline workflow from samples to clinical results.

Related Links:
Thermo Fisher Scientific Inc. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.